Skip to content

Return to the Full Article View You can republish this story for free. Click the "Copy HTML" button below. Questions? Get more details.

Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug

Kaiser Health News’ Shefali Luthra spoke with Jeremy Hobsons, host of WBUR’s Hear & Now, about the Trump administration’s lawsuit over sales of the HIV-prevention drug Truvada.

You can read the text of the lawsuit here.

Check out this earlier, related California Healthline story: Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk (Luthra and Gorman, 7/16/2018).

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact khnweb@kff.org.